JR Ingelfinger

Julie R. Ingelfinger is a Professor of Pediatrics at Harvard Medical School and a senior physician in the Division of Nephrology at Boston Children's Hospital. She earned her medical degree from Harvard Medical School and completed her residency and fellowship training in pediatrics and nephrology at Massachusetts General Hospital and Boston Children's Hospital, respectively. Dr. Ingelfinger's research program focuses on the developmental origins of health and disease, with particular emphasis on how early-life factors—from birth through childhood—influence long-term cardiovascular and renal health. Her work centers on the renin-angiotensin system's role in hypertension and kidney injury, employing multiomics approaches to understand target-organ damage in youth with primary hypertension. A major theme of her research is elucidating the hormonal and molecular mechanisms linking early developmental perturbations to adult cardiovascular disease, with recent investigations exploring renal tubule-specific gene deletion effects on mitochondrial dysfunction and senescence in diabetic kidney models. She also studies cross-talk between endothelial and renal tubular cells in ischemia-reperfusion injury. Dr. Ingelfinger has authored nearly 500 publications, maintains an h-index of 66, and serves as a senior editor for the New England Journal of Medicine, where she contributes to scholarly discourse on diabetes therapeutics and cardiovascular medicine. Her research has been recognized through numerous invited lectureships and editorial roles in leading nephrology and hypertension journals.